Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1952 1
1970 1
1974 1
1979 1
1986 1
1988 2
1990 2
1995 1
1996 1
1999 1
2000 1
2001 1
2002 2
2003 7
2004 4
2005 5
2006 3
2007 3
2008 1
2009 2
2010 4
2011 9
2012 5
2013 5
2014 8
2015 8
2016 11
2017 8
2018 6
2019 8
2020 10
2021 3
2024 0

Text availability

Article attribute

Article type

Publication date

Similar articles for PMID: 29741503

117 results

Results by year

Filters applied: . Clear all
Page 1
A closer look at copanlisib.
Dreyling M. Dreyling M. Clin Adv Hematol Oncol. 2018 Jan;16(1):35-37. Clin Adv Hematol Oncol. 2018. PMID: 29741503 No abstract available.
Copanlisib: Novel PI3K Inhibitor for the Treatment of Lymphoma.
Kumar A, Bhatia R, Chawla P, Anghore D, Saini V, Rawal RK. Kumar A, et al. Anticancer Agents Med Chem. 2020;20(10):1158-1172. doi: 10.2174/1871520620666200317105207. Anticancer Agents Med Chem. 2020. PMID: 32183683 Review.
[Molecular target therapy for malignant tumors].
[No authors listed] [No authors listed] Nihon Naika Gakkai Zasshi. 2005 Feb 20;94 Suppl:76-80. Nihon Naika Gakkai Zasshi. 2005. PMID: 15796061 Review. Japanese. No abstract available.
Targeting PI3K Signaling in Combination Cancer Therapy.
Pons-Tostivint E, Thibault B, Guillermet-Guibert J. Pons-Tostivint E, et al. Trends Cancer. 2017 Jun;3(6):454-469. doi: 10.1016/j.trecan.2017.04.002. Epub 2017 May 14. Trends Cancer. 2017. PMID: 28718419 Review.
117 results